Bausch Health
Update in progressBHC (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Bausch Health Companies Inc. is a global specialty pharmaceutical and medical device company that develops, manufactures, and markets products across gastroenterology, hepatology, neurology, dermatology, generic medicines, OTC products, aesthetic devices, and eye health. It operates through five segments—Salix, International, Solta Medical, Diversified, and Bausch + Lomb—serving the US and international markets. Formerly Valeant, it is based in Laval, Canada.
Company score
- Sentiment
- -0.39
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.40
- Governance
- -0.31
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.19
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.29
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!